Drugs / STX-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00878761 | Sep 2010 → Oct 2011 | chronic transplant rejection | Stromedix, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STX-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00878761 ↗ |
| Route | Subcutaneous | “SC, single dose followed by multiple dose” NCT00878761 ↗ |